Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.
Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.We wish to raise the success rate to COVID-19 patients with respiratory failure.More critically ill COVID-19 patients could avoid the intubtion.
Study Type
OBSERVATIONAL
Enrollment
23
noninvasive ventilation to support the COVID-19 patients with respiratory failure
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
success rate
the sucess rate of the noninvasive ventilation
Time frame: 4 month
the intubtion rate
the intubtion rate of the COVID-19 patients
Time frame: 4 month
blood lymphocyte
blood lymphocyte of the COVID-19 patients
Time frame: 4month
B-type natriuretic peptide
blood B-type natriuretic peptide of the COVID-19 patients
Time frame: 4 month
Procalcitonin
blood procalcitonin of the COVID-19 patients
Time frame: 4 month
Oxygen Saturation
Oxygen Saturation of the COVID-19 patients
Time frame: 4 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.